Anteris Technologies Global (AVR) Set to Post Earnings on Wednesday

Anteris Technologies Global (NASDAQ:AVR) is expected to be releasing its Q3 2026 resultson Wednesday, November 11th. Analysts expect Anteris Technologies Global to post earnings of ($0.3114) per share and revenue of $2.75 million for the quarter. Parties may review the information on the company’s upcoming Q3 2026 earnings report page for the latest details on the call scheduled for Tuesday, November 17, 2026 at 4:00 PM ET.

Anteris Technologies Global (NASDAQ:AVR) last released its quarterly earnings results on Tuesday, August 11th. The company reported ($0.30) EPS for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.09). The firm had revenue of $1.01 million for the quarter, compared to analysts’ expectations of $1.50 million. Anteris Technologies Global had a negative net margin of 4,619.27% and a negative return on equity of 77.69%. During the same quarter last year, the firm earned ($0.58) earnings per share. On average, analysts expect Anteris Technologies Global to post ($1.21) EPS for the current fiscal year and ($0.96) EPS for the next fiscal year.

Anteris Technologies Global Trading Up 5.6%

Shares of AVR opened at $5.91 on Wednesday. Anteris Technologies Global has a 12-month low of $3.30 and a 12-month high of $11.06. The company has a market cap of $576.28 million, a PE ratio of -3.05 and a beta of 2.02. The stock has a 50-day moving average price of $7.43 and a 200-day moving average price of $7.38.

Insider Buying and Selling at Anteris Technologies Global

In other Anteris Technologies Global news, major shareholder L1 Capital Pty Ltd acquired 648,455 shares of the stock in a transaction on Monday, October 5th. The stock was acquired at an average price of $7.51 per share, for a total transaction of $4,869,897.05. Following the completion of the transaction, the insider directly owned 12,778,380 shares of the company’s stock, valued at $95,965,633.80. This trade represents a 5.35% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In the last ninety days, insiders bought 1,554,730 shares of company stock worth $11,694,513 and sold 810,180 shares worth $7,270,974. 4.50% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on AVR shares. Cantor Fitzgerald restated an “overweight” rating and issued a $15.00 price objective on shares of Anteris Technologies Global in a report on Wednesday, October 14th. Weiss Ratings restated a “sell (d-)” rating on shares of Anteris Technologies Global in a report on Wednesday, August 26th. Finally, Barclays raised Anteris Technologies Global to a “hold” rating in a research report on Wednesday, October 7th. Three equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $14.00.

About Anteris Technologies Global

Anteris Technologies Global is a medical device company focused on developing structural heart products for the treatment of heart valve disease. Its primary focus is transcatheter aortic valve replacement (TAVR), a minimally invasive procedure used to replace a diseased aortic valve without traditional open-heart surgery.

The company’s lead product is the DurAVR transcatheter heart valve, which is designed to replicate the function and hemodynamic performance of a healthy human aortic valve.